Join us as we discuss diagnosis and treatment options of ovarian cancer, update new concepts for DCIS and breast cancer, review algorithms for pain management that allow us to omit narcotics for post-operative pain management, and more. We’ll also review the detection and management of early rectal cancers. In addition, we will feature a live demonstration of advanced perfusion techniques.
Physicians, Nurse Practitioners, Physician Assistants, Nurses, Fellows, Residents, Students and Other Interested Healthcare Providers
Jointly Provided By
Creighton University School of Medicine
Department of Medicine Office of Continuing Education CHI Health
4.25 CE hours Remote viewing locations: CHI Health Good Samaritan, room D/E/F CHI Health St. Francis, room 2/3 CHI Health St. Elizabeth, Franciscan Conference Room Objectives
Describe the rationale and evolution of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC)
Review outcomes of CS+HIPEC
Discuss patient selection for CS+HIPEC
Describe DCIS and its pre-invasive cancer state
Review treatment options for DCIS
Describe the differences between DCIS and LCIS
Discuss the challenges in the diagnosis of ovarian cancer
Explain the new diagnostic assays available to the clinician in differentiating benign from malignant ovarian cysts
Discuss examples of new investigator-initiated targeted therapies for the treatment of chemotherapy resistant ovarian cancer
Review the indications for the use of veno-venous bypass to enhance the safety of selected major abdominal or retroperitoneal procedures
Demonstrate how the procedure is put into practice
Demonstrate how HIPEC is safely applied after cytoreductive surgery
Describe the evidence-based algorithms that allow us in many cases to avoid the use of parental or oral narcotics after major abdominal surgery
Review how pre-operative prescription of narcotics can interfere with post-operative pain management
Define goals of local excision techniques in early stage rectal cancer
Identify patients who may be candidates for local excision with early stage rectal cancer
Review surveillance guidelines and define indications for rectal resection in patients with early stage rectal cancer
7 a.m. Registration, Continental Breakfast and Visit Exhibits
7:30 a.m. Introduction and Management of Primary and Metastatic Peritoneal Cancers Brian W. Loggie, MD
8 a.m. Ductal Carcinoma In-Site (DCIS) or Pre-invasive Breast Cancer Michael J. McNamara, MD, FACS
9 a.m. The Diagnosis and Treatment of Ovarian Cancer: From the Research Bench to the Patient Bedside Robin Farias-Eisner, MD, PhD
10 a.m. Working Break Advanced Perfusion Techniques: Veno-Venous Bypass and HIPEC Perfusion Noelle Meyer, MA, CCP, LP Hugh Gass, CCP, LP, CPBMT
10:15 a.m. Enhanced Recovery After Surgery Mark Reisbig, MD
11 a.m. Management of Early Stage Rectal Cancer Devi Mukkai Krishnamurty, MBBS 12 p.m. Closing Remarks Brian W. Loggie, MD In Memory of Michael David Smith
February 17, 1944–May 13, 2019
This symposium has been made possible by the estate of Michael David Smith. Michael was a former patient of Dr. Brian W. Loggie and a committed supporter of philanthropic initiatives. In 2004, Michael was diagnosed with a rare appendix disease called pseudomyxoma peritonei. He battled it with courage and strength, even reaching out to others suffering from this little-known disease, offering knowledge and support.
At the end of his life when asked what he loved to do most, Michael answered, “Mow my lawn and take long walks.” A devoted father and grandfather, Michael was a man who enjoyed a simple life. He had a vibrant and welcoming personality, lighting up the room with every entrance. He made everyone feel special and made sure they knew how much he appreciated them. His loving heart brought joy and smiles to all who were blessed to know him. He is deeply missed.
Category 1 Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit(s) . Physicians should claim only the credit commensurate with the extent of their participation in the activity. TM
AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.
Nurse CE Creighton University Health Sciences Continuing Education designates this activity for 4.25 contact hour(s) for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education (HSCE) and CHI Health. Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
$10 for live and remote viewing